These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37641989)

  • 1. Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats.
    Molobekova CA; Kondaurova EM; Ilchibaeva TV; Rodnyy AY; Stefanova NA; Kolosova NG; Naumenko VS
    Curr Alzheimer Res; 2023; 20(7):496-505. PubMed ID: 37641989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride as a potential disease-modifying drug in the treatment of tauopathies.
    Jahreis K; Brüge A; Borsdorf S; Müller FE; Sun W; Jia S; Kang DM; Boesen N; Shin S; Lim S; Koroleva A; Satała G; Bojarski AJ; Rakuša E; Fink A; Doblhammer-Reiter G; Kim YK; Dityatev A; Ponimaskin E; Labus J
    Alzheimers Dement; 2023 Dec; 19(12):5482-5497. PubMed ID: 37218673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 MAPK-dependent alphaB-crystallin phosphorylation in Alzheimer's disease-like pathology in OXYS rats.
    Muraleva NA; Kolosova NG; Stefanova NA
    Exp Gerontol; 2019 May; 119():45-52. PubMed ID: 30664924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.
    Stefanova NA; Kozhevnikova OS; Vitovtov AO; Maksimova KY; Logvinov SV; Rudnitskaya EA; Korbolina EE; Muraleva NA; Kolosova NG
    Cell Cycle; 2014; 13(6):898-909. PubMed ID: 24552807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids from Stems and Leaves of
    Shengkai D; Yazhen S
    CNS Neurol Disord Drug Targets; 2022; 21(4):367-374. PubMed ID: 34455972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat.
    Wang XC; Zhang J; Yu X; Han L; Zhou ZT; Zhang Y; Wang JZ
    Sheng Li Xue Bao; 2005 Feb; 57(1):7-12. PubMed ID: 15719129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the prefrontal cortex after the hippocampus was injected with Aβ
    Wang Y; Sheng H; Zhao J; Guo L; Liu J; Xu J; Liu Q; Huang J; Jiang R; Gan S; Qiu G; Lu W; Xu S; Zhu S
    Neurosci Lett; 2021 Jan; 741():135453. PubMed ID: 33186609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Porphyromonas gingivalis and Its Underlying Mechanisms on Alzheimer-Like Tau Hyperphosphorylation in Sprague-Dawley Rats.
    Tang Z; Liang D; Cheng M; Su X; Liu R; Zhang Y; Wu H
    J Mol Neurosci; 2021 Jan; 71(1):89-100. PubMed ID: 32557144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
    Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.
    Stefanova NA; Muraleva NA; Maksimova KY; Rudnitskaya EA; Kiseleva E; Telegina DV; Kolosova NG
    Aging (Albany NY); 2016 Oct; 8(11):2713-2733. PubMed ID: 27750209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
    Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
    J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.
    Yang Y; Zhang J; Ma D; Zhang M; Hu S; Shao S; Gong CX
    J Alzheimers Dis; 2013; 37(3):637-48. PubMed ID: 23948890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic noise on the corticotropin-releasing factor system in the rat hippocampus: relevance to Alzheimer's disease-like tau hyperphosphorylation.
    Gai Z; Su D; Wang Y; Li W; Cui B; Li K; She X; Wang R
    Environ Health Prev Med; 2017 Dec; 22(1):79. PubMed ID: 29228900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats.
    Zeng K; Li M; Hu J; Mahaman YAR; Bao J; Huang F; Xia Y; Liu X; Wang Q; Wang JZ; Yang Y; Liu R; Wang X
    Curr Alzheimer Res; 2018; 15(1):89-99. PubMed ID: 28847282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic gonadotropin decreases the phosphorylated tau protein level in streptozotocin-Alzheimeric male rats' hippocampus.
    Bahlakeh G; Jahanshahi M; Saeidi M
    Folia Neuropathol; 2018; 56(2):141-150. PubMed ID: 30509034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
    Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
    Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of MAP 1A regulates hyperphosphorylation of Tau in Alzheimer's disease model.
    Cai B; Shao N; Ye T; Zhou P; Si W; Song H; Wang G; Kou J
    Neuropathol Appl Neurobiol; 2023 Oct; 49(5):e12934. PubMed ID: 37705167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.